Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)
Others
Ratios

CervoMed (CRVO) Restructuring Costs (2024 - 2025)

CervoMed (CRVO) has disclosed Restructuring Costs for 2 consecutive years, with $177518.0 as the latest value for Q4 2025.

  • Quarterly Restructuring Costs rose 56.71% to $177518.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $473646.0 through Dec 2025, changed N/A year-over-year, with the annual reading at $610561.0 for FY2025, 93.9% up from the prior year.
  • Restructuring Costs hit $177518.0 in Q4 2025 for CervoMed, up from $110972.0 in the prior quarter.
  • In the past five years, Restructuring Costs ranged from a high of $177518.0 in Q4 2025 to a low of $71878.0 in Q3 2024.